ORTI B Stock Overview
Develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Ortivus AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 1.80 |
52 Week High | SEK 3.92 |
52 Week Low | SEK 1.46 |
Beta | 0.60 |
11 Month Change | 12.15% |
3 Month Change | 2.27% |
1 Year Change | -41.94% |
33 Year Change | -67.15% |
5 Year Change | -56.73% |
Change since IPO | -98.00% |
Recent News & Updates
Shareholder Returns
ORTI B | SE Healthcare Services | SE Market | |
---|---|---|---|
7D | 0% | 0.8% | -2.1% |
1Y | -41.9% | 51.5% | 10.8% |
Return vs Industry: ORTI B underperformed the Swedish Healthcare Services industry which returned 51.5% over the past year.
Return vs Market: ORTI B underperformed the Swedish Market which returned 10.8% over the past year.
Price Volatility
ORTI B volatility | |
---|---|
ORTI B Average Weekly Movement | 6.1% |
Healthcare Services Industry Average Movement | 5.9% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 11.2% |
10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: ORTI B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: ORTI B's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 32 | Gustaf Nordenhok | www.ortivus.com |
Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient’s vital parameters, such as ECG, blood pressure, and blood oxygenation; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services.
Ortivus AB (publ) Fundamentals Summary
ORTI B fundamental statistics | |
---|---|
Market cap | SEK 81.55m |
Earnings (TTM) | -SEK 17.79m |
Revenue (TTM) | SEK 77.96m |
1.0x
P/S Ratio-4.5x
P/E RatioIs ORTI B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ORTI B income statement (TTM) | |
---|---|
Revenue | SEK 77.96m |
Cost of Revenue | SEK 49.60m |
Gross Profit | SEK 28.36m |
Other Expenses | SEK 46.15m |
Earnings | -SEK 17.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.40 |
Gross Margin | 36.38% |
Net Profit Margin | -22.82% |
Debt/Equity Ratio | 1,445.4% |
How did ORTI B perform over the long term?
See historical performance and comparison